Policy → market
Market alerts
Not financial advice
Commercial cliffs from presidential documents — role pressure, mechanisms, and a curated issuer watchlist. Policy exposure mapping — not investment advice. Illustrative public companies are incomplete and not recommendations.
How this works
- Cliff vs glide — dates that change market access differ from multi-year programs.
- Role pressure — protective / adverse / mixed for supply-chain roles (not a stock tip).
- Named issuers — curated watchlist only.
- Price window — optional EOD chart around issue and cliff dates; coincidence, not causation.
- in 40dIssued Apr 9, 2026
Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States
Tariffs effective for other companies
MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson - in 207dIssued Mar 5, 2026
Continuation of the National Emergency With Respect to Iran
Continued national emergency expires unless renewed again
MMM3MALBAlbemarleBACBank of AmericaBASFYBASFBLKBlackRockBABoeingLNGCheniere EnergyCVXChevron - in 884dIssued Apr 9, 2026
Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States
Zero tariff rate expires for companies with MFN pricing agreements
MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson - in 1321dIssued Apr 9, 2026
Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States
20% onshoring rate increases to 100%
MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson